Current strategies for improvements in the treatment of Alzheimer's disease

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Recent research shows new drug developments targeting beta-amyloid and tau in Alzheimer's disease, indicating potential future improvements.

New drug developments targeting beta-amyloid and tau have shown promise yet failed in phase 3 trials.
Animals models have improved cognitive function, but the same benefits are not observed in Alzheimer's patients.
Gene therapy trials offer hope for restoring neuronal function and enhancing cognitive abilities in patients.
A better understanding of inflammation and oxidative stress may lead to the development of new treatment strategies.

Alharbi et al. (2024) studied this question.

View Full Paper

Ask AI

Bookmark

Recent research shows new drug developments targeting beta-amyloid and tau in Alzheimer's disease, indicating potential future improvements.